Search Results - "Kogawa, T"

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer by Fujii, T., Kogawa, T., Dong, W., Sahin, A.A., Moulder, S., Litton, J.K., Tripathy, D., Iwamoto, T., Hunt, K.K., Pusztai, L., Lim, B., Shen, Y., Ueno, N.T.

“…Although 1% has been used as cut-off for estrogen receptor (ER) positivity, several studies have reported that tumors with ER < 1% have characteristics similar…”
Get full text

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun by Xie, X, Kaoud, T S, Edupuganti, R, Zhang, T, Kogawa, T, Zhao, Y, Chauhan, G B, Giannoukos, D N, Qi, Y, Tripathy, D, Wang, J, Gray, N S, Dalby, K N, Bartholomeusz, C, Ueno, N T

“…c-Jun N-terminal kinase (JNK) plays a vital role in malignant transformation of different cancers, and JNK is highly activated in basal-like triple-negative…”
Get full text

346P Phase I study of the liposomal formulation of eribulin (E7389-LF): Results from the HER2-negative breast cancer expansion by Tamura, K., Takahashi, S., Mukohara, T., Tanioka, M., Yasojima, H., Ono, M., Naito, Y., Shimoi, T., Otani, Y., Kobayashi, K., Kogawa, T., Suzuki, T., Takase, T., Matsunaga, R., Masuda, N.

Get full text

Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results from a phase I/II trial by Yonemori, K., Masuda, N., Takahashi, S., Kogawa, T., Nakayama, T., Yamamoto, Y., Takahashi, M., Toyama, T., Saeki, T., Iwata, H.

Get full text

P145 Postpartum breast cancer diagnosed within 10 years of last childbirth is a prognostic factor for distant metastasis – analysis of lymphovascular invasion relating factors by Iesato, A., Ueno, T., Takahashi, Y., Kataoka, A., Matsunaga, Y., Saeki, S., Ozaki, Y., Inoue, Y., Maeda, T., Uehiro, N., Kobayashi, T., Sakai, T., Takano, T., Kogawa, T., Kitano, S., Ono, M., Osako, T., Ohno, S.

Get full text

Abstract PD1-03: Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results of a phase 1/2 trial by Masuda, N, Yonemori, K, Takahashi, S, Kogawa, T, Nakayama, T, Iwase, H, Takahashi, M, Toyama, T, Saeki, T, Saji, S, Inoue, K, Onuma, H, Tajima, N, Shiose, Y, Chen, S, Guevara, F, Yu, C, Ueno, S, Iwata, H

“…Abstract Background: Human epidermal growth factor receptor 3 (HER3) is overexpressed in a variety of solid tumors, including breast cancer. However, there are…”
Get full text

Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non‐erosive reflux disease – a double‐blind, placebo‐controlled study by Miwa, H., Inoue, K., Ashida, K., Kogawa, T., Nagahara, A., Yoshida, S., Tano, N., Yamazaki, Y., Wada, T., Asaoka, D., Fujita, T., Tanaka, J., Shimatani, T., Manabe, N., Oshima, T., Haruma, K., Azuma, T., Yokoyama, T.

“…Aliment Pharmacol Ther 2011; 33: 323–332 Summary Background  Proton pump inhibitors (PPIs) are less effective in non‐erosive reflux disease (NERD) patients…”
Get full text

P-055Prospective evaluation for chemotherapy-induced nausea and vomiting in colorectal cancer receiving oxaliplatin-based chemotherapy of moderate emetic risk by Shimokawa, M, Hayashi, T, Kogawa, T, Matsui, R, Suzuki, K, Saeki, T, Aiba, K, Tamura, K

Get full text

Addressing the knowledge gap in the genomic landscape and tailored therapeutic approaches to adolescent and young adult cancers by Hayashi, N., Ono, M., Fukada, I., Yamazaki, M., Sato, N., Hosonaga, M., Wang, X., Kaneko, K., Arakawa, H., Habano, E., Kuga, A., Kataoka, A., Ueki, A., Kiyotani, K., Tonooka, A., Takeuchi, K., Kogawa, T., Kitano, S., Takano, T., Watanabe, M., Mori, S., Takahashi, S.

“…Adolescents and young adults (AYAs) represent a small proportion of patients with cancer. The genomic profiles of AYA patients with cancer are not…”
Get full text

628 Predictive factors for pain relief by strontium 89 chloride in patients with bone metastases by Yokoyama, T, Sasaki, M, Naito, Y, Kogawa, T, Yamada, Y, Onomura, M, Matsubara, N, Zenda, S, Hosono, A, Hirofumi, M

Get full text

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer by Park, K.H., Loibl, S., Sohn, J., Park, Y.H., Jiang, Z., Tadjoedin, H., Nag, S., Saji, S., Md. Yusof, M., Villegas, E.M.B., Lim, E.H., Lu, Y.-S., Ithimakin, S., Tseng, L.-M., Dejthevaporn, T., Chen, T.W.-W., Lee, S.C., Galvez, C., Malwinder, S., Kogawa, T., Bajpai, J., Brahma, B., Wang, S., Curigliano, G., Yoshino, T., Kim, S.-B., Pentheroudakis, G., Im, S.-A., Andre, F., Ahn, J.B., Harbeck, N.

“…The European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer…”
Get full text

1597 Prognosis of leptomeningeal metastasis diagnosed by magnetic resonance imaging in 329 patients with advanced solid tumors by Urasaki, T, Naito,, Y, Sasaki, M, Matsubara, N, Hosono, A, Kogawa,, T, Kuno, H, Kobayashi, T, Kusumoto, M, Niho, S, Goto, K, Yoshino, T, Mukai, H

Get full text

P1-196 The characteristics of reactive oxygen metabolites detected in the serum of early Japanese teenagers by Kogawa, T, Kurauchi, S, Nishimura, M, Kashiwakura, I

“…IntroductionThe level of reactive oxygen metabolites in the serum of healthy early Japanese teenagers was analysed to determine the current state of oxidative…”
Get full text

Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer by Kogawa, T., Doi, A., Shimokawa, M., Fouad, T. M., Osuga, T., Tamura, F., Mizushima, T., Kimura, T., Abe, S., Ihara, H., Kukitsu, T., Sumiyoshi, T., Yoshizaki, N., Hirayama, M., Sasaki, T., Kawarada, Y., Kitashiro, S., Okushiba, S., Kondo, H., Tsuji, Y.

“…Cetuximab-containing treatments for metastatic colorectal cancer have been shown to have higher overall response rates and longer progression-free and overall…”
Get full text

Successful treatment for gastro-intestinal bleeding of Osler-Weber-Rendu disease by argon plasma coagulation using double-balloon enteroscopy by Sato, Y, Takayama, T, Takahari, D, Sagawa, T, Sato, T, Abe, S, Kogawa, T, Nikaido, T, Miyanishi, K, Takahashi, S, Kato, J, Niitsu, Y

Get more information

Possible paracrine growth of adenocarcinoma of the stomach induced by granulocyte colony stimulating factor produced by squamous cell carcinoma of the oesophagus by Ichiishi, E, Yoshikawa, T, Kogawa, T, Yoshida, N, Kondo, M

“…Synchronous cancers of the oesophagus and stomach diagnosed in a patient showing pronounced leucocytosis were examined for production of granulocyte colony…”
Get full text

55O Phase I study of H3B-6545 in patients (pts) with estrogen receptor-positive (ER+) breast cancer by Ono, M., Kogawa, T., Kitano, S., Shimoi, T., Yamamoto, K., Kobayashi, S., Ichikawa, Y., Yamaguchi, K., Otake, Y., Hojo, S., Yonemori, K.

Get full text

264P Increased membrane HER3 expression in brain metastases compared to primary tumors in breast cancer by Kusuhara, S., Kogawa, T., Shimokawa, M., Funasaka, C., Kondoh, C.N., Harano, K., Matsubara, N., Naito, Y., Hosono, A., Satomi, K., Yoshida, M., Fujii, S., Ohnishi, T., Suto, A., Yonemori, K., Koyama, K., Maeda, N., Narita, Y., Mukohara, T.

Get full text

151OSingle agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results from a phase I/II trial by Yonemori, K, Masuda, N, Takahashi, S, Kogawa, T, Nakayama, T, Yamamoto, Y, Takahashi, M, Toyama, T, Saeki, T, Iwata, H

Get full text

LBA4 Datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate (ADC), for triple-negative breast cancer (TNBC): Preliminary results from an ongoing phase I trial by Bardia, A., Juric, D., Shimizu, T., Tolcher, A., Karim, R., Spira, A., Mukohara, T., Lisberg, A.E., Kogawa, T., Krop, I., Papadopoulos, K.P., Hamilton, E., Damodaran, S., Greenberg, J., Gu, W., Kobayashi, F., Guevara, F., Jikoh, T., Kawasaki, Y., Meric-Bernstam, F.

Get full text